AP NEWS

Clovis Oncology to Announce Fourth Quarter/Fiscal Year 2018 Financial Results and Host Webcast Conference Call on February 26

February 12, 2019

BOULDER, Colo.--(BUSINESS WIRE)--Feb 12, 2019--Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its fourth quarter/fiscal year 2018 financial results on Tuesday, February 26, 2019, before the open of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 8:30 a.m. ET to discuss the company’s results in greater detail.

The conference call is being webcast and can be accessed from the Clovis Oncology website at www.clovisoncology.com. A replay of the webcast will be available for 30 days.

Conference Call Details

Clovis will hold a conference call to discuss Q4/FY 2018 results on Tuesday, February 26, at 8:30am ET. The conference call will be simultaneously webcast on the Company’s web site at www.clovisoncology.com, and archived for future review. Dial-in numbers for the conference call are as follows: US participants 866.393.4306, International participants 734.385.2616, conference ID: 6675335.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado; please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190212005143/en/

CONTACT: Clovis Investor Contacts:

Anna Sussman

303.625.5022

asussman@clovisoncology.com

or

Breanna Burkart

303.625.5023

bburkart@clovisoncology.com

KEYWORD: UNITED STATES NORTH AMERICA COLORADO

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS HOSPITALS ONCOLOGY PHARMACEUTICAL MEDICAL SUPPLIES

SOURCE: Clovis Oncology

Copyright Business Wire 2019.

PUB: 02/12/2019 08:00 AM/DISC: 02/12/2019 08:01 AM

http://www.businesswire.com/news/home/20190212005143/en

AP RADIO
Update hourly